VERA Vera Therapeutics Inc Yalpi foyda normasi

Vera Therapeutics Inc (VERA) korporativ emblemasi va logotipi

Vera Therapeutics, Inc. (VERA) maxsus oqsillarga e'tibor qaratgan holda buyrak patologiyalari uchun noyob terapiyalarni ishlab chiqadi. Ushbu yalpi foyda marjasi grafigi moliyaviy samaradorlikni namoyish etadi, bunda joriy ko'rsatkich 56.60 ni tashkil etadi. Antitelolarga bo'lgan eksklyuziv huquqlar va FDA ning qat'iy nazorati biznesni raqobatchilardan himoya qiladi. Shu bilan birga, kapitalga kirish bevosita klinik sinovlar natijalari va R&D xarajatlarining nazoratiga bog'liq.

veratx.com (VERA) Yalpi foyda bo'yicha rentabellik: 04.07.2022 - 20.11.2026 davri uchun

Vera Therapeutics, Inc. (VERA) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- pul pozitsiyasi va pul oqimlari tafsilotlari:
Fundamental baholash:VERA Vera Therapeutics Inc
Vera Corp yetakchi tovari

Yalpi foyda marjasi bevosita ishlab chiqarish xarajatlari chegirib tashlanganidan keyin qolgan daromad qismini o'lchaydi va bu birlik uchun foyda yaratishning fundamental samaradorligini baholash imkonini beradi. Tijoriy mahsulotlari bo'lmagan Vera Therapeutics, Inc. (VERA) uchun yalpi foyda marjasi darajasi sheriklik to'lovlari va investitsiya oqimlarining daromadliligini aks ettiradi hamda investorlar e'tiborini dori vositalarini bozorga chiqarishdan oldin R&D infratuzilmasini saqlash xarajatlariga qaratadi.

Asosiy raqobatchilar

argenx - Yalpi foyda normasi|Yalpi rentabellik biontech.de|ABIVAX (ABVX) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja ADMA|Yalpi foyda koeffitsiyenti PTGX|Yalpi rentabellik Immunovant Corp IMVT|Yalpi marja Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Yalpi foyda bo'yicha rentabellik|Aurinia Pharmaceuticals Inc. (AUPH) - Yalpi marja|Yalpi foyda bo'yicha rentabellik BCRX|Dianthus Pharma (DNTH) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Pharvaris Pharma (PHVS)|Yalpi marja AbCellera Corp (ABCL)|Yalpi marja TRML (Tourmaline Bio Inc)|Yalpi foyda bo'yicha sotuv rentabelligi precigen.com (PGEN)|PHAR - Yalpi rentabellik|Yalpi foyda normasi NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Yalpi foyda bo'yicha rentabellik|Zenas Corp (ZBIO) - Yalpi marja|Yalpi foyda bo'yicha rentabellik IMNM|GOSS: Yalpi foyda normasi|Yalpi rentabellik KalVista Pharma (KALV)|SEPN - Yalpi foyda marjasi|Yalpi marja PVLA (pieris.com)|Yalpi marja Savara Pharma SVRA|RIGL: Yalpi foyda bo'yicha rentabellik|ANAB - Yalpi marja|ATXS: Yalpi marja|ENGN - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi foyda bo'yicha rentabellik RAPT|JBIO (Aerovate Therapeutics Inc) - Yalpi foyda koeffitsiyenti|Yalpi marja ACRS|Yalpi foyda bo'yicha rentabellik kyvernatx.com KYTX|Yalpi marja TLSA (Tiziana Life Sciences, Ltd.)|Yalpi marja Cabaletta Bio CABA|VTYX: Yalpi foyda bo'yicha rentabellik|Theratechnologies Inc. (THTX) - Yalpi foyda bo'yicha rentabellik|AVTX: Yalpi marja|ELDN - Yalpi foyda bo'yicha sotuv rentabelligi|AGEN (Agenus, Inc) - Yalpi marja|Yalpi marja Climb Bio, Inc.|Yalpi rentabellik Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Yalpi foyda normasi|Yalpi marja ADAG (Adagene Inc)|IMA - Yalpi foyda bo'yicha rentabellik|STTK - Yalpi rentabellik|EQ (equilliumbio.com) - Sotuvning yalpi rentabelligi|CNTB: Yalpi marja|Immunic Inc (IMUX) - Yalpi marja|ATRA (Atara Biotherapeutics Inc) - Yalpi marja|Sotuvning yalpi rentabelligi IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Yalpi foyda normasi|Adicet Bio, Inc. - Sotuvning yalpi rentabelligi|Celularity Inc - Yalpi foyda bo'yicha rentabellik|Yalpi marja INmune Bio Corporation INMB|Barinthus Biotherapeutics - Yalpi marja|Kezar Life Sciences, Inc. (KZR) - Yalpi foyda bo'yicha rentabellik|SAB Biotherapeutics Inc. (SABS) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Akari Therapeutics plc|Yalpi rentabellik enlivex.com|q32bio.com (QTTB) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja GOVX|Edesa Biotech, Inc. - Sotuvning yalpi rentabelligi|iBio Inc - Yalpi foyda bo'yicha rentabellik|Yalpi marja Carisma Therapeutics CARM|XTLB - Yalpi rentabellik|BOLT (boltbio.com) - Sotuvning yalpi rentabelligi|HCWB: Yalpi marja|Aptevo (APVO) - Yalpi marja|Yalpi rentabellik AIM ImmunoTech|Yalpi foyda bo'yicha rentabellik Aditxt (ADTX)|Yalpi foyda bo'yicha rentabellik GRI (GRI Bio Corporation)|XORTX - Sotuvning yalpi rentabelligi|Yalpi marja HIND (Vyome Holdings Inc.)|Yalpi foyda normasi REVB|Indaptus - Yalpi marja|SCNI (Scinai Immunotherapeutics Ltd.) - Sotuvning yalpi rentabelligi|CALI: Yalpi marja|Affimed NV - Yalpi foyda normasi|Yalpi rentabellik Allakos Inc.|Yalpi marja HOOKIPA Pharma|Yalpi rentabellik IGM Biosciences, Inc. (IGMS)|ITOS - Yalpi foyda marjasi|Yalpi marja OCEA (Ocean Bio)|Yalpi foyda normasi TCBP|THRD - Yalpi rentabellik